Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000179:Acrylates; D000328:Adult; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D008297:Male; D008689:Methacrylates / Q000097:blood; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011817:Rabbits; D013929:Thromboxane B2 / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors* / Q000097:blood; D013931:Thromboxanes / Q000097:blood*
D000179:Acrylates; D008689:Methacrylates; D013931:Thromboxanes; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C031517:2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase